Stock Quality:
Last 7 days
-29.9%
Last 30 days
-29.9%
Last 90 days
-27.7%
Trailing 12 Months
-81.9%
YCBD RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Revenue Breakdown
|
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2025 | 19.6M | 19.0M | 0 | 0 |
2024 | 22.4M | 21.1M | 19.9M | 19.7M |
2023 | 30.1M | 27.7M | 25.1M | 24.2M |
2022 | 41.5M | 39.1M | 37.1M | 33.5M |
2021 | 48.6M | 49.2M | 47.3M | 44.1M |
2020 | 39.8M | 40.8M | 43.2M | 45.9M |
2019 | 14.3M | 21.2M | 28.1M | 37.8M |
2018 | 6.8M | 8.2M | 459.1K | 7.4M |
2017 | 4.0M | 4.7M | 5.4M | 5.7M |
2016 | 0 | 0 | 2.6M | 3.3M |
CEO | Mr. T. Ronan Kennedy |
---|---|
WEBSITE | cbdmd.com |
SECTOR | Healthcare |
INDUSTRY | Drug Manufacturers Specialty & Generic |
EMPLOYEES | 90 |